Glycine can be well tolerated in some trials without 10 g a day being necessary or safe for everyone. The best-documented side effects here include digestive symptoms. Small sample sizes, limited durations and selected populations prevent any promise of general safety.
This article concerns glycine, the amino acid sold as a dietary supplement, not the climbing plant called wisteria, known as glycine in French. Its aim is to check combined intake and precautions, not to propose a new sleep protocol.
Which glycine are we talking about?
Glycine is a building block of proteins that your body can also produce. It is involved in several metabolic pathways and neurotransmission. Its normal presence in the body does not prove that adding any given amount is useful or harmless.
Free glycine powder, collagen peptides and a GlyNAC blend are not the same product. The first directly supplies the added amino acid. Collagen contains glycine within its proteins or peptides. GlyNAC combines glycine and N-acetylcysteine: its effects and tolerability cannot automatically be attributed to glycine alone.
The report by the Norwegian committee VKM distinguishes dietary and supplemental intake in its assessment. Keep these categories separate in your audit too.
If your question concerns the plant: the information below does not apply to ingestion of flowers, seeds or pods of Wisteria. The SFMU toxicology fact sheet concerns this plant. If ingestion is suspected, contact a poison control centre without waiting for symptoms to appear. In France, call 15 or 112 in the event of respiratory distress or loss of consciousness.
Side effects: what the evidence allows us to say
The phrase “well tolerated” means that researchers observed tolerability deemed acceptable within their protocol. It does not mean “no events” and does not automatically tell us anything about several years of use.
Here is what the studies consulted allow us to distinguish:
| Effect or question | Available observation | Uncertainty to retain |
|---|---|---|
| Loose stools, abdominal discomfort or pain | Digestive symptoms reported in a small study at 9 g a day | Frequency in the population, individual threshold and effect of prolonged use |
| Nausea | Reported in a trial in adults with alcohol use disorder | Applicability to a healthy adult, a different amount or a blend |
| Headache, fatigue, dizziness | Mild events reported in the same trial | Individual causality and usual frequency outside this context |
| Next-day drowsiness | No signal of residual drowsiness in the 9 g study | Guaranteed absence in everyone, especially with other ingredients |
| Rare risks, combined intake over several years | The cited trials do not adequately address this question | A reassuring small trial cannot rule out a rare event |
A tolerability study at 9 g for seven days
The study by Inagawa and colleagues, published in 2006, included 12 healthy adults. They received 9 g a day for seven days, initially divided after meals, then as a single dose during the day and finally at bedtime.
The authors observed no serious acute events and reported laboratory changes that remained within physiological ranges. Some digestive symptoms were considered possibly related to bedtime intake. The authors were affiliated with Ajinomoto.
This is short-term tolerability evidence from an open-label trial with different dosing schedules used in succession. It cannot establish a threshold at which symptoms begin or certify daily use for years.
A recent trial in a specific population
A trial published in 2025 by Olsson and colleagues studied five days of glycine in adults with alcohol use disorder. The protocol used a weight-adjusted amount of 0.12 g/kg a day, divided into three doses. This figure describes the research, not an amount to adopt.
The reported events were mild and none led to treatment discontinuation. They included headache, fatigue, nausea and dizziness. There were too few events for a reliable statistical analysis. These findings therefore cannot be treated as an overall frequency of side effects among glycine users.
The same trial did not demonstrate an overall reduction in alcohol consumption in the laboratory. It does not justify using glycine to treat an addiction on your own or make alcohol less risky.
Studied doses and duration: why they do not prove general safety
A research amount must always be accompanied by the population and duration studied. Simply saying “patients took much more” removes precisely the information needed to make a decision.
The systematic review by Soh and colleagues identified highly heterogeneous studies. Within its included studies, administration in healthy adults lasted up to 14 days, compared with four months in some patient populations. The authors particularly highlight small sample sizes and risks of bias in sleep studies. The literature search ended in April 2022, so this review does not cover the 2025 trial described above.
Our guide to glycine and the claims surrounding 10 g examines the benefits. Safety remains a separate question: a studied amount is neither a demonstrated daily requirement nor an upper limit valid for everyone.
In 2016, VKM assessed specified supplemental intakes of 20 to 650 mg a day, considered unlikely to cause adverse effects in the age groups assessed. This conclusion does not cover 10 g. The report also highlights insufficient human data to construct its dose–response assessment. It does not provide a universal ceiling to copy.
The absence of a sufficiently established general limit does not mean there is no biological limit. It means we do not have the universal number that marketing would love to print on the tub.
Combined intake: audit the amounts actually declared
The easiest mistake is not always choosing a high amount. It is losing sight of the fact that several products supply the same substance.
The “Pill Cupboard” refers to this accumulation of supplements without knowing which one does what. For glycine, it may include powder, a sleep blend, a longevity formula and collagen. The first job is an inventory, not fine-tuning the cocktail.
Educational example: entirely fictional labels
The products, formulations and amounts below are invented to explain the calculation. They do not correspond to any brand and are not a recommendation for use. The illustration for this article also features fictional packaging.
| Fictional product | What the fictional label declares | Use chosen for the calculation | Identified intake |
|---|---|---|---|
| Powder A | Free glycine: 3 g per serving | 1 serving | 3 g of free glycine |
| Sleep blend B | Glycine: 1.5 g per 5 g serving | 2 servings | 3 g of free glycine, not 10 g |
| GlyNAC formula C | Glycine: 1 g and NAC: 1 g per serving | 1 serving | 1 g of free glycine, not 2 g |
| Collagen D | Peptides: 10 g per serving, including glycine: 2 g according to the supplied profile | 1 serving | 2 g of glycine contained in proteins |
In this example, the subtotal of added free glycine is 7 g : 3 + 3 + 1. Collagen separately provides 2 g declared within proteins, making 9 g identified in these supplements, not counting food.
This total describes declared masses. It does not demonstrate that 9 g of glycine from different forms is equivalent to taking 9 g of free glycine, or that this combined intake is safe or useful. The collagen profile chosen here is fictional: do not reuse it to calculate the amount in another product.
Your combined-intake worksheet
Copy the available information without turning a blank field into a zero:
| Product and batch | Declared glycine per serving | Servings actually taken per day | Added free glycine per day | Declared glycine from proteins | Unknown to check |
|---|---|---|---|---|---|
| Product 1 | Record | Record | Calculate if known | Record separately | Amount, form or composition |
| Product 2 | Record | Record | Calculate if known | Record separately | Amount, form or composition |
| Product 3 | Record | Record | Calculate if known | Record separately | Amount, form or composition |
The basic calculation is amount per serving × servings per day. Check whether the label gives values for one capsule, two capsules, one scoop or a full serving. Convert milligrams to grams before adding: 1,000 mg equals 1 g.
If a 5 g blend contains glycine, magnesium and other ingredients without detailing each amount, 5 g is not 5 g of glycine. Record “not quantifiable from the label” and ask the manufacturer or pharmacist for the composition.
Do not convert the weight of elemental magnesium in a bisglycinate into an amount of ingested glycine either. That would require precise information about the formula and its composition. For collagen, a product-specific amino acid profile is preferable to a generic percentage found elsewhere. If it is missing, retain that uncertainty.
This worksheet is not a complete dietary assessment. Protein in meals also supplies glycine. Its primary purpose is to reveal overlap between products and missing information.
Pregnancy, medical conditions and treatments: when to seek advice
For the following groups and situations, the evidence is not sufficiently applicable to justify supplementation without professional guidance:
| Situation | What is missing or needs checking | Cautious decision |
|---|---|---|
| Pregnancy or breastfeeding | Relevant data on concentrated, prolonged supplementation | Do not start without professional advice |
| Child or adolescent | Adult trials are not sufficient for general consumer use | Seek age-appropriate advice without extrapolating an adult amount |
| Kidney or liver disease | Uncertain applicability of findings from selected volunteers | Have the indication, total amount and necessary monitoring checked |
| Psychiatric treatment, particularly clozapine | Combination studied in small trials, with no established benefit alongside clozapine and findings requiring interpretation by the psychiatrist | Do not add glycine or change the medication on your own |
| Multiple medications or a blend with many ingredients | Interactions and tolerability of the complete product insufficiently understood | Have all formulations reviewed together |
It would be an overstatement to claim that these populations have never been studied. Patients, and sometimes minors in specialist settings, appear in the literature. The limitation is whether those findings apply to your product, your goal and unsupervised use.
Regarding clozapine, a small 1999 trial raised the possibility of interference with treatment effectiveness. Another trial in 2000 found neither a significant benefit nor a clinically significant worsening in assessments. These findings do not justify certainty about an interaction at low amounts, but they are enough to leave the decision to the psychiatrist.
Precautions for a blend are not limited to those for glycine. NAC, melatonin and other ingredients need their own checks. Our GlyNAC analysis · FR distinguishes the combination from the amino acid alone. The guide to glycine, magnesium and GABA for sleep examines the benefits without making combined intake a requirement.
If a symptom appears: do not normalise it
Diarrhoea or discomfort after starting a product is not proof of a “detox”. Record the timing, amounts and all ingredients. Stop taking the suspected supplement and seek advice if symptoms persist, recur or are pronounced. Do not alter a prescribed medication to compensate.
Repeated vomiting, significant pain or a deterioration in general condition require prompt assessment. If you have difficulty breathing, throat swelling or loss of consciousness, call 15 or 112 in France. This advice addresses serious signs without claiming that they are usual effects of glycine.
If an accidentally high amount is taken or a child ingests it, keep the packaging and contact a poison control centre, without waiting for symptoms or making up a toxic threshold. A suspected adverse effect can also be reported through the ANSES nutrivigilance scheme, ideally with a healthcare professional. It does not replace medical care.
The Verdict
Frequently asked questions
Can glycine cause digestive problems?
Yes. Loose stools and abdominal pain were reported in a small tolerability trial. Nausea appears in another clinical setting. The amount taken, the complete product and other causes should be examined before attributing a symptom to glycine alone.
Is 10 g a day suitable for everyone?
No. The literature does not support making it a universal standard. An amount tolerated by selected participants for a few days does not become a guarantee for several years, pregnancy or someone with an illness.
How do you count intake from a blend?
Use the declared amount of glycine per serving, multiplied by the servings actually consumed. If only the blend’s total mass is given, the calculation is impossible. Record free glycine, glycine declared within proteins and unknown amounts separately.
Which populations lack data?
The safety of prolonged supplementation remains insufficiently documented for pregnancy, breastfeeding and many uses in minors or people taking multiple medications. A trial in certain patients under supervision does not validate use in everyone with the same condition.
Sources and method
Documentary synthesis consulted on 19 October 2026. The amounts cited describe protocols, not personal recommendations. The educational packaging and labels are fictional. This selection is neither a systematic review nor a medical consultation.
